Antifungal activity of Rubus chingii extract combined with fluconazole against fluconazole-resistant Candida albicans

Microbiology and Immunology

Volumn 60, Issue 2, 2016, Pages 82-92

  Han, Bing ^a   Chen, Jia ^a   Yu, Yi Qun ^a   Cao, Yong Bing ^b   Jiang, Yuan Ying ^b  

^a FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Candida albicans; Fluconazole; Rubus Chingii; Synergy

Indexed keywords

ANTIFUNGAL AGENT; ERGOSTEROL; FLUCONAZOLE; PLANT EXTRACT; RHODAMINE 6G; RUBUS CHINGII EXTRACT; UNCLASSIFIED DRUG; RHODAMINE;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; APOPTOSIS; ARTICLE; CANDIDA ALBICANS; CELL ULTRASTRUCTURE; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; FUNGAL CELL; FUNGAL STRAIN; FUNGUS GROWTH; G1 PHASE CELL CYCLE CHECKPOINT; IN VITRO STUDY; MASS FRAGMENTOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; PHYTOCHEMISTRY; RUBUS; RUBUS CHINGII; S PHASE CELL CYCLE CHECKPOINT; ANTIFUNGAL RESISTANCE; CELL CYCLE; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; DRUG POTENTIATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; TRANSMISSION ELECTRON MICROSCOPY;

ANTIFUNGAL AGENTS; APOPTOSIS; CANDIDA ALBICANS; CELL CYCLE; CELL MEMBRANE; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; ERGOSTEROL; FLUCONAZOLE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; PLANT EXTRACTS; RHODAMINES; RUBUS;

EID: 84958559070     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12357     Document Type: Article

References (31)

1. Mora C., Tittensor D.P., Adl S., Simpson A.G., Worm B. (2011) How many species are there on Earth and in the ocean? PLoS Biol 9: 1-8.
2. Brown G.D., Denning D.W., Levitz S.M. (2012) Tackling human fungal infections. Science 336: 647.
3. Gow N.A., Van De Veerdonk F.L., Brown A.J., Netea M.G. (2012) Candida albicans morphogenesis and host defence: Discriminating invasion from colonization. Nat Rev Microbiol 10: 112-22.
4. Ge S.-H., Xie J., Xu J., Li J., Li D.-M., Zong L.-L., Zheng Y.-C., Bai F.-Y. (2012) Prevalence of specific and phylogenetically closely related genotypes in the population of Candida albicans associated with genital candidiasis in China. Fungal Genet Biol 49: 86-93.
5. Williams D., Lewis M. (2011) Pathogenesis and treatment of oral candidosis. J Oral Microbiol 3; doi: 10.3402/jom.v3i0.5771.
6. Sangeorzan J.A., Bradley S.F., He X., Zarins L.T., Ridenour G.L., Tiballi R.N., Kauffman C.A. (1994) Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 97: 339-46.
7. Dixon D.M., Mcneil M.M., Cohen M.L., Gellin B.G., La Montagne J.R. (1996) Fungal infections: a growing threat. Public Health Rep 111: 226.
8. Kumar A., Thakur S., Thakur V.C., Kumar A., Patil S., Vohra M. (2012) Antifungal activity of some natural essential oils against Candida species isolated from blood stream infection. J Krishna Inst Med Sci Univ 1: 61-6.
9. Barchiesi F., Najvar L.K., Luther M.F., Scalise G., Rinaldi M.G., Graybill J.R. (1996) Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model. Antimicrob Agents Chemother 40: 1317-20.
10. Boken D.J., Swindells S., Rinaldi M.G. (1993) Fluconazole-resistant Candida albicans. Clin Infect Dis 17: 1018-21.
11. Patel A., Rojas-Vera J., Dacke C. (2004) Therapeutic constituents and actions of Rubus species. Curr Med Chem 11: 1501-12.
12. Tzouwara-Karayanni S., Philianos S. (1981) Chemical constituents of Rubus ulmifolius Schott. Pharm Biol 19: 127-30.
13. Krauze-Baranowska M., Majdan M., Halasa R., Glód D., Kula M., Fecka I. Orzel A. (2014) The antimicrobial activity of fruits from some cultivar varieties of Rubus idaeus and Rubus occidentalis. Food Funct 5: 2536-41.
14. Zhang T.-T., Jiang J.-G. (2014) Analyses on essential oil components from the unripe fruits of Rubus chingii Hu by different methods and their comparative cytotoxic and anti-complement activities. Food Anal Methods 8: 937-44.
15. Barchiesi F., Di Francesco L.F., Scalise G. (1997) In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles. Antimicrob Agents Chemother 41: 1812-4.
16. Cai Y., Fan Y., Wang R., An M.-M., Liang B.-B. (2009) Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model. J Antimicrob Chemother 64: 563-6.
17. Onyewu C., Blankenship J.R., Del Poeta M., Heitman J. (2003) Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob Agents Chemother 47: 956-64.
18. Brouwer A.E., Rajanuwong A., Chierakul W., Griffin G.E., Larsen R.A., White N.J., Harrison T.S. (2004) Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet 363: 1764-7.
19. Johnson M.D., Macdougall C., Ostrosky-Zeichner L., Perfect J.R., Rex J.H. (2004) Combination antifungal therapy. Antimicrob Agents Chemother 48: 693-715.
20. Zhang T.-T., Lu C.-L., Jiang J.-G., Wang M., Wang D.-M., Zhu W. (2015) Bioactivities and extraction optimization of crude polysaccharides from the fruits and leaves of Rubus chingii Hu. Carbohydr Polym 130: 307-15.
21. Ying Y., Zhao Y., Hu X., Cai Z., Liu X., Jin G., Zhang J., Zhang J., Liu J., Huang X. (2013) In vitro fluconazole susceptibility of 1, 903 clinical isolates of Candida albicans and the identification of ERG11 mutations. Microb Drug Resist 19: 266-73.
22. Vertut-Croquin A., Bolard J., Chabbert M., Gary-Bobo C. (1983) Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol-or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study. Biochemistry 22: 2939-44.
23. Suresh Kumar G. (2014) The abundance of Ergosterol in Candida species does not influence fluconazole sensitivity. Biophys J 106: 704a-05a.
24. Bossche, H.V., Willemsens, G., Marichal, P. (1987) Anti-Candida drugs-the biochemical basis for their activity. CRC Crit Rev Microbiol 15: 57-72.
25. Weinert T.A., Hartwell L.H. (1988) The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241: 317-22.
26. Coste A., Selmecki A., Forche A., Diogo D., Bougnoux M.-E., D'enfert C., Berman J., Sanglard D. (2007) Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryotic Cell 6: 1889-904.
27. Kanafani Z.A., Perfect J.R. (2008) Resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 46: 120-28.
28. Holmes A.R., Lin Y.-H., Niimi K., Lamping E., Keniya M., Niimi M., Tanabe K., Monk B.C., Cannon R.D. (2008) ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother 52: 3851-62.
29. Park S., Perlin D.S. (2005) Establishing surrogate markers for fluconazole resistance in Candida albicans. Microb Drug Resist 11: 232-8.
30. Barker K.S., Pearson M.M., Rogers P.D. (2003) Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae. J Antimicrob Chemother 51: 1131-40.
31. Ribeiro M.A., Paula C., Perfect J.R., Cox G.M. (2005) Phenotypic and genotypic evaluation of fluconazole resistance in vaginal Candida strains isolated from HIV-infected women from Brazil. Med Mycol 43: 647-50.